Disc Medicine (IRON) Change in Account Payables (2020 - 2026)

Disc Medicine's (IRON) quarterly Change in Account Payables came in at $2.7 million in Q1 2026, up 314.64% year-on-year from $661049.5 in Q1 2025, and up 56.63% on a QoQ basis from $1.8 million in Q4 2025.

Disc Medicine (IRON) Change in Account Payables (2020 - 2026) Analysis & Trends

Disc Medicine (IRON) has 7 years of Change in Account Payables data on file, last reported at $2.7 million in Q1 2026.

  • On a quarterly basis, Change in Account Payables rose 314.64% year-over-year to $2.7 million in Q1 2026; TTM through Mar 2026 was $5.1 million, a 262.91% increase from a year earlier, with the FY2025 full-year figure at $1.1 million, up 122.86% from the prior year.
  • Change in Account Payables for Q1 2026 stood at $2.7 million, up from $1.8 million in the prior quarter.
  • Over the last five years, Change in Account Payables for IRON reached as high as $4.4 million in Q4 2024 and fell as low as -$10.8 million in Q1 2023.
  • Historically, Change in Account Payables has averaged -$240294.1 across 5 years, with a median of -$321000.0 in 2025.
  • On a YoY basis, Change in Account Payables climbed as much as 5463.51% in 2023 and fell as far as 994.7% in 2023.
  • Year by year, Change in Account Payables stood at -$74000.0 in 2022, then jumped by 5463.51% to $4.0 million in 2023, then grew by 10.73% to $4.4 million in 2024, then sank by 60.18% to $1.8 million in 2025, then soared by 56.63% to $2.7 million in 2026.
  • Per Business Quant data, the three most recent Change in Account Payables figures were $2.7 million in Q1 2026, $1.8 million in Q4 2025, and $918000.0 in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Account Payables (Qtr)
1 Oculis Holding AG 66,140.12 Bn 66,139.83 Bn - -
2 Nanobiotix 1,933.82 Bn 1,933.76 Bn - -
3 Akari Therapeutics 1,022.34 Bn 1,022.34 Bn - -
4 BeOne Medicines 472.04 Bn 467.25 Bn 1.35 Bn -42.19 Mn
5 Vertex Pharmaceuticals 122.28 Bn 115.03 Bn 2.59 Bn 35.60 Mn
6 Regeneron Pharmaceuticals 70.07 Bn 61.31 Bn 3.31 Bn -
7 Belite Bio 62.66 Bn 62.66 Bn - -
8 Argenx Se 56.16 Bn 50.98 Bn 1.41 Bn -
9 Alnylam Pharmaceuticals 37.56 Bn 34.55 Bn 959.66 Mn -
10 Disc Medicine 2.88 Bn 2.88 Bn - 2.74 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 2.74 Mn
Mar 31, 2026 2.74 Mn
Dec 31, 2025 1.75 Mn
Dec 31, 2025 1.75 Mn
Sep 30, 2025 918,000.00
Sep 30, 2025 918,000.00
Jun 30, 2025 -321,000.00
Jun 30, 2025 -321,000.00
Mar 31, 2025 -1.28 Mn
Mar 31, 2025 -1.28 Mn
Dec 31, 2024 4.40 Mn
Dec 31, 2024 4.40 Mn
Sep 30, 2024 -1.05 Mn
Sep 30, 2024 -1.05 Mn
Jun 30, 2024 -669,000.00
Jun 30, 2024 -669,000.00
Mar 31, 2024 -7.36 Mn
Mar 31, 2024 -7.36 Mn
Dec 31, 2023 3.97 Mn
Dec 31, 2023 3.97 Mn